Chronic Urticaria Patients More Likely to Have IBS, SIBO: Study Suggests Medha Baranwal26 March 2026 8:30 PM ISTUSA: Researchers have reported a potential link between chronic idiopathic urticaria and certain gastrointestinal disorders, including irritable bowel...
CVD Linked to Increased nonmelanoma skin cancer Risk via Obesity and Inflammation: Study Dr. Shravani Dali25 March 2026 10:00 PM ISTResearchers have found in a new study that cardiovascular disease (CVD) is associated with a higher risk of developing nonmelanoma skin cancer (NMSC),...
Dupilumab Improves Itch and Disease Activity in Chronic Spontaneous Urticaria Regardless of BMI, Gender: Study Medha Baranwal24 March 2026 9:00 PM ISTUSA: A study published in The Journal of Allergy and Clinical Immunology reports that Dupilumab significantly reduced itch severity and disease...
Prolonged Ruxolitinib Cream Shows Repigmentation in Vitiligo Despite Early Minimal Response: Study Medha Baranwal24 March 2026 8:45 PM ISTUSA: A new study has revealed that prolonged treatment with ruxolitinib cream may still lead to significant repigmentation in patients with vitiligo...
Anifrolumab Shows Promising 6-Month Outcomes in SLE: Lancet Dr. Shravani Dali23 March 2026 9:30 PM ISTIn a real-world, multicenter cohort study published in The Lancet Rheumatology, anifrolumab demonstrated positive results in patients with systemic...
Ritlecitinib Effective and Well-Tolerated for Severe Alopecia Areata, suggests study Dr Riya Dave22 March 2026 8:30 PM ISTResearchers have found in a multicentre real-world study that ritlecitinib 50 mg/day was found to be an effective and well-tolerated treatment for...
Linezolid Comparable to Clindamycin in Severe or Necrotizing SSTIs, Suggests Study Medha Baranwal20 March 2026 8:45 PM ISTUSA: Researchers have found in a new study that linezolid and clindamycin show similar effectiveness in treating severe or necrotizing skin and soft...
Icotrokinra Shows Strong Efficacy and Safety in Plaque Psoriasis: Meta-Analysis Medha Baranwal19 March 2026 8:30 PM ISTLibya: New research, published in the International Journal of Dermatology, has demonstrated high efficacy and good tolerability of oral icotrokinra...
Hidradenitis Suppurativa Linked to Higher Risk of Self-Harm and Suicide: JAMA Medha Baranwal18 March 2026 8:45 PM ISTDenmark: A large Danish registry-based study has found that patients with hidradenitis suppurativa had about twice the rate of self-harm, including...
Semaglutide Improves Clinical and Metabolic Outcomes in Hidradenitis Suppurativa with Obesity: Study Medha Baranwal18 March 2026 10:00 AM ISTSpain: A new study has found that treatment with Semaglutide in patients with Hidradenitis Suppurativa and obesity led to improvements in weight, body...
FDA Approves Deucravacitinib for Active Psoriatic Arthritis Dr. Kamal Kant Kohli16 March 2026 8:15 PM ISTThe U.S. Food and Drug Administration has approved Deucravacitinib (Sotyktu) for the treatment of adults with Psoriatic Arthritis. This oral drug is a...
Nemolizumab Demonstrates Sustained Long-Term Benefit in Prurigo Nodularis: Study Dr. Kamal Kant Kohli15 March 2026 9:30 PM ISTLong-term results from the OLYMPIA open-label extension study show that nemolizumab (Nemluvio) provides durable efficacy and good tolerability for up...
